>
Switch to:

Corcept Therapeutics EV-to-Revenue

: 6.90 (As of Today)
View and export this data going back to 2004. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Corcept Therapeutics's enterprise value is $2,441.9 Mil. Corcept Therapeutics's Revenue for the trailing twelve months (TTM) ended in Dec. 2020 was $353.9 Mil. Therefore, Corcept Therapeutics's EV-to-Revenue for today is 6.90.

NAS:CORT' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.8   Med: 11.45   Max: 414.9
Current: 6.89
2.8
414.9

During the past 13 years, the highest EV-to-Revenue of Corcept Therapeutics was 414.90. The lowest was 2.80. And the median was 11.45.

NAS:CORT's EV-to-Revenue is ranked higher than
75% of the 910 Companies
in the Biotechnology industry.

( Industry Median: 22.20 vs. NAS:CORT: 6.89 )

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2021-03-06), Corcept Therapeutics's stock price is $24.550000. Corcept Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was $2.85. Therefore, Corcept Therapeutics's PS Ratio for today is 8.61.

Corcept Therapeutics EV-to-Revenue Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Corcept Therapeutics Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.61 12.46 5.29 3.63 8.13

Corcept Therapeutics Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.63 3.16 4.39 4.48 8.13
Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.

Corcept Therapeutics EV-to-Revenue Distribution

* The bar in red indicates where Corcept Therapeutics's EV-to-Revenue falls into.


Corcept Therapeutics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Corcept Therapeutics's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=2441.873/353.874
=6.90

Corcept Therapeutics's current Enterprise Value is $2,441.9 Mil.
Corcept Therapeutics's Revenue for the trailing twelve months (TTM) ended in Dec. 2020 was 93.247 (Mar. 2020 ) + 88.565 (Jun. 2020 ) + 86.327 (Sep. 2020 ) + 85.735 (Dec. 2020 ) = $353.9 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Corcept Therapeutics  (NAS:CORT) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Corcept Therapeutics's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=24.550000/2.852
=8.61

Corcept Therapeutics's share price for today is $24.550000.
Corcept Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was 0.763 (Mar. 2020 ) + 0.719 (Jun. 2020 ) + 0.694 (Sep. 2020 ) + 0.676 (Dec. 2020 ) = $2.85.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Corcept Therapeutics EV-to-Revenue Related Terms

Corcept Therapeutics EV-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)